Mirati Therapeutics, Inc. (MRTX) Reaches $24.75 52-Week High; The Hartford Financial Services Group, Inc. (HIG) Covered By 10 Bullish Analysts Last Week

January 14, 2018 - By Adrian Mccoy

Among 18 analysts covering Hartford Financial (NYSE:HIG), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Hartford Financial had 47 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Monday, October 9 with “Buy”. The firm has “Buy” rating given on Thursday, July 27 by Keefe Bruyette & Woods. Keefe Bruyette & Woods maintained the shares of HIG in report on Thursday, November 2 with “Buy” rating. The firm has “Hold” rating given on Wednesday, December 20 by Citigroup. The firm has “Buy” rating by RBC Capital Markets given on Friday, July 28. The firm has “Buy” rating given on Tuesday, September 5 by RBC Capital Markets. The rating was upgraded by Atlantic Securities to “Overweight” on Tuesday, January 26. The stock of The Hartford Financial Services Group, Inc. (NYSE:HIG) has “Buy” rating given on Monday, June 26 by Keefe Bruyette & Woods. Buckingham Research initiated The Hartford Financial Services Group, Inc. (NYSE:HIG) rating on Monday, September 11. Buckingham Research has “Buy” rating and $63.0 target. On Tuesday, December 19 the stock rating was upgraded by Credit Suisse to “Outperform”. See The Hartford Financial Services Group, Inc. (NYSE:HIG) latest ratings:

20/12/2017 Broker: Citigroup Rating: Hold New Target: $59.0 Initiate
19/12/2017 Broker: Credit Suisse Old Rating: Neutral New Rating: Outperform Upgrade
04/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $66.0 Maintain
04/12/2017 Broker: RBC Capital Markets Rating: Buy New Target: $63.0 Maintain
04/12/2017 Broker: Goldman Sachs Rating: Neutral New Target: $59 Initiates Coverage On
02/11/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $60.0 Maintain
01/11/2017 Broker: UBS Rating: Buy Old Target: $60 New Target: $62 Maintain
16/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $61 New Target: $64 Maintain
09/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $61.0 Maintain
11/09/2017 Broker: Buckingham Research Rating: Buy New Target: $63.0 Initiate

The stock of Mirati Therapeutics, Inc. (NASDAQ:MRTX) hit a new 52-week high and has $26.24 target or 6.00% above today’s $24.75 share price. The 5 months bullish chart indicates low risk for the $690.94M company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $26.24 price target is reached, the company will be worth $41.46M more. The stock increased 6.68% or $1.55 during the last trading session, reaching $24.75. About 955,072 shares traded or 108.04% up from the average. Mirati Therapeutics, Inc. (NASDAQ:MRTX) has declined 76.51% since January 14, 2017 and is downtrending. It has underperformed by 93.21% the S&P500.

Investors sentiment increased to 0.83 in Q3 2017. Its up 0.08, from 0.75 in 2017Q2. It is positive, as 40 investors sold The Hartford Financial Services Group, Inc. shares while 210 reduced holdings. 63 funds opened positions while 144 raised stakes. 310.47 million shares or 1.93% less from 316.59 million shares in 2017Q2 were reported. Natixis Asset Mngmt holds 0.01% or 2,129 shares in its portfolio. Diamond Hill Capital Mngmt Inc accumulated 1.59% or 5.44M shares. Sei Invests has 146,842 shares for 0.03% of their portfolio. Estabrook Capital Mgmt owns 700 shares. Advsrs Asset Mgmt reported 2,177 shares stake. Andra Ap holds 108,300 shares or 0.14% of its portfolio. Ajo Limited Partnership has 0% invested in The Hartford Financial Services Group, Inc. (NYSE:HIG) for 14,046 shares. Tortoise Inv Mgmt Limited Liability holds 0.01% of its portfolio in The Hartford Financial Services Group, Inc. (NYSE:HIG) for 500 shares. Acadian Asset Mngmt reported 24,055 shares or 0.01% of all its holdings. Mufg Americas holds 2,300 shares or 0% of its portfolio. Ahl Limited Liability Partnership has invested 0.04% of its portfolio in The Hartford Financial Services Group, Inc. (NYSE:HIG). Chevy Chase Incorporated has invested 0.08% in The Hartford Financial Services Group, Inc. (NYSE:HIG). Citigroup reported 0.01% in The Hartford Financial Services Group, Inc. (NYSE:HIG). Public Employees Retirement System Of Ohio invested in 0.05% or 158,054 shares. U S Global Investors invested in 9,283 shares or 0.19% of the stock.

The stock increased 0.36% or $0.2 during the last trading session, reaching $55.29. About 2.57 million shares traded or 24.09% up from the average. The Hartford Financial Services Group, Inc. (NYSE:HIG) has risen 9.92% since January 14, 2017 and is uptrending. It has underperformed by 6.78% the S&P500.

The Hartford Financial Services Group, Inc., through its subsidiaries, provides insurance and financial services to individual and business clients in the United States. The company has market cap of $19.72 billion. It operates through six divisions: Commercial Lines, Personal Lines, Property & Casualty Other Operations, Group Benefits, Mutual Funds, and Talcott Resolution. It has a 42.05 P/E ratio. The Commercial Lines segment offers workersÂ’ compensation, property, automobile, marine, livestock, liability, and umbrella insurance products, as well as customized insurance services and products, including professional liability, bond, and specialty casualty coverages.

Investors sentiment increased to 1.17 in Q3 2017. Its up 0.49, from 0.68 in 2017Q2. It improved, as 16 investors sold Mirati Therapeutics, Inc. shares while 7 reduced holdings. 13 funds opened positions while 14 raised stakes. 13.25 million shares or 19.85% more from 11.06 million shares in 2017Q2 were reported. Deutsche Fincl Bank Ag owns 16,545 shares. Meeder Asset Mngmt owns 396 shares. Pdt Partners Limited Company holds 0.03% or 68,200 shares. Jpmorgan Chase Company, a New York-based fund reported 2,777 shares. Venbio Select Advisor Ltd Com accumulated 3.37% or 3.71M shares. Citadel Advisors Llc holds 0% in Mirati Therapeutics, Inc. (NASDAQ:MRTX) or 22,855 shares. Two Sigma Secs Ltd holds 0.02% in Mirati Therapeutics, Inc. (NASDAQ:MRTX) or 19,559 shares. Cormorant Asset Management Limited Co reported 1.00 million shares. Pnc Finance Group Inc stated it has 92 shares. Jane Street Group Limited Liability Co owns 57,127 shares. Barclays Public Ltd Company has 12,500 shares for 0% of their portfolio. State Street has invested 0% of its portfolio in Mirati Therapeutics, Inc. (NASDAQ:MRTX). Bnp Paribas Arbitrage invested 0% in Mirati Therapeutics, Inc. (NASDAQ:MRTX). Moreover, Baker Bros Advsrs L P has 0.22% invested in Mirati Therapeutics, Inc. (NASDAQ:MRTX) for 2.27M shares. Geode Capital holds 0% or 169,685 shares.

Since September 15, 2017, it had 0 insider purchases, and 2 selling transactions for $65,240 activity. Shares for $9,240 were sold by Christensen Jamie.

Analysts await Mirati Therapeutics, Inc. (NASDAQ:MRTX) to report earnings on March, 8. They expect $-0.65 earnings per share, up 34.34% or $0.34 from last year’s $-0.99 per share. After $-0.65 actual earnings per share reported by Mirati Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>